ArticleJournal of neuroendovascular therapy2026
Improved Luminal Visualization of Flow Diverters after Deployment Using Non-Contrast-Enhanced 3D-TOF-MRA: A Comparison between the Flow-Redirection Endoluminal Device and the Pipeline Flex Embolization Device with Shield Technology.
Article in Journal of neuroendovascular therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to improve the accuracy of luminal evaluation of flow diverters (FDs) using non-contrast-enhanced 3D time-of-flight MRA (3D-TOF-MRA). Methods: The Flow-Redirection Endoluminal Device (FRED) and Pipeline Flex Embolization Device with Shield Technology (Pipeline) were deployed in phantom vessels with an inner diameter of 4 mm, and a phantom vessel without an FD was used as the reference. A diluted Gd contrast agent, adjusted to achieve a T1 relaxation time equivalent to that of blood, was circulated through the phantom vessels under steady flow conditions. Non-contrast-enhanced 3D-TOF-MRA images were acquired with varying echo time (TE), flip angle (FA), and Tilted Optimized Non-Saturating Excitation (TONE) ramp settings. Source images obtained from the central and edge regions of the stents were used to evaluate the relative in-stent signal (RIS) and lumen area ratio. In addition, the signal difference between the inflow and outflow regions was calculated and assessed as the saturation ratio. Results: RIS values for both FRED and Pipeline decreased with increasing TE at both the central and edge regions. A similar decreasing trend was observed for the area ratio. Overall, FRED demonstrated relatively higher RIS and area ratio values than Pipeline. Regarding the FA variation, the peak RIS at the center regions occurred at an FA of 35° for both FDs, followed by a plateau. In the TONE ramp analysis, a setting of 30% yielded a saturation ratio closest to 100%. Conclusion: These findings suggest that luminal visualization of FDs can be improved by optimizing 3D-TOF-MRA acquisition parameters, particularly the TE, FA, and TONE ramp settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.